Infuvite IV (Ascorbic Acid 200 mg+ Vitamin A Acetate 330 IU+Vitamin D3 200 IU+Thiamine HCL 6 mg+Riboflavin-5-Phosphate Sod 3.6 mg+Pyridoxine HCL 6 mg+Niacinamide 40 mg+Dexpanthenol 15 mg+Vitamin 40E Succinate 10 IU+Phytonadione (K1) 150 mcg/5 mL). 30 ML. Compounded by Tri-Coast Pharmacy.

Lack of Assurance of Sterility

Recall #: D-0264-2017
Affected scope: 161 vials
Initiated: November 17, 2016

Compiled from official public sources by the publisher. · Updated September 2026

Tri-Coast Pharmacy recalled Infuvite IV (Ascorbic Acid 200 mg+ Vitamin A Acetate 330 IU+Vitamin D3 200 IU+Thiamine HC… - a moderate-severity action.

Infuvite IV (Ascorbic Acid 200 mg+ Vitamin A Acetate 330 IU+Vitamin D3 200 IU+Thiamine HC… was recalled by Tri-Coast Pharmacy in January 11, 2017. Reason: Lack of Assurance of Sterility. Check the official notice for the remedy. Verify recall #D-0264-2017 with the FDA Drug before acting.

The recall

Tri-Coast Pharmacy issued this moderate-severity FDA Drug recall-Lack of Assurance of Sterility.

Moderate
severity level: Class II
classification: January 11, 2017
reported

Sourced from official FDA Drug enforcement records. Verify recall #D-0264-2017 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This recall's affected scope, documented in the Recall Profile below, stays within a single-region or limited-distribution footprint. Distribution scope (see Distribution below) directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Where this agency-classified recall sits among FDA Class I/II/III notices

Of 88,244 recalls with an agency hazard classification, 19,068 are high severity, 64,652 moderate, and 4,524 low. A further 16,179 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified moderate severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Product description

Infuvite IV (Ascorbic Acid 200 mg+ Vitamin A Acetate 330 IU+Vitamin D3 200 IU+Thiamine HCL 6 mg+Riboflavin-5-Phosphate Sod 3.6 mg+Pyridoxine HCL 6 mg+Niacinamide 40 mg+Dexpanthenol 15 mg+Vitamin 40E Succinate 10 IU+Phytonadione (K1) 150 mcg/5 mL). 30 ML. Compounded by Tri-Coast Pharmacy.

Reason for recall

Lack of Assurance of Sterility

Recall Profile

Structured summary of the FDA Drug recall record
Attribute	Value
Agency	U.S. Food and Drug Administration
Severity class	Moderate (Class II)
Status	Ongoing
Recall number	D-0264-2017
Date reported	January 11, 2017
Date initiated	November 17, 2016
Recalling firm	Tri-Coast Pharmacy
Firm location	Juno Beach, FL
Affected scope	161 vials
Distribution	Nationwide

Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

Check the recall number (D-0264-2017) and product description against the item you own. Search the archive
Confirm the current status with FDA Drug before acting, recall details can be updated.
Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled? ▼

Why was this product recalled? ▼

Lack of Assurance of Sterility

Which agency issued this recall? ▼

This recall was issued by the FDA Drug on January 11, 2017. Severity: Moderate. Recall number: D-0264-2017.

Where was the recalled product distributed? ▼

Distribution: Nationwide.

Should I stop using a recalled medication or medical device? ▼

Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nationwide recalls with similar severity or category timing

Drug and device notices outside this firm and state, matched by severity timing and product category.

Similar severity · nearest report date

Same archive severity grade (Moderate), closest by report date among other firms and states.

Textron Specialized Vehicles Recalls Bad … 2017-01-11 Arctic Cat Recalls Snowmobiles Due to Fir… 2017-01-11 Linon Home Décor Recalls Dressers Due to … 2017-01-11 Gentell Hydrogel Ag Saturated Gauze, 2"x… 2017-01-11

Similar Dietary Supplements · nearest report date

Same product category, closest by report date among other firms and states (deduped against the severity set).

Liquid VITAMIN D-3 Drops distributed unde… 2017-01-04 CANNIBAL FEROX AMPED, FACE-MELTING NOOTRO… 2016-12-28 Rx CHOICE brand LIQUID VITAMIN C, 16 FL O… 2016-12-28 Rx CHOICE brand LIQUID VITAMIN C, 16 FL O… 2016-12-28

Compare this recall with Goody King Magnetic Building Cubes and Blocks Recalled Due … → · All Dietary Supplements recalls

This recall: FDA Drug, reported January 11, 2017. Severity classes follow each agency's own taxonomy; related-recall context is computed across the full archive.

Methodology · Corrections · Archive as of August 2026